Clinical trial
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
NCT07050433
Study timeline
Study start (actual)2025-08-07Date precision: day
Registry last updated2026-08-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
CXCR2 as a biomarkerDIAGNOSTIC_TEST
Sponsors & collaborators
Duke Universitylead sponsor
Prostate Cancer Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07050433 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.